CORDIS
EU research results

CORDIS

English EN

A Centre of Excellence in Computational Biomedicine

Project information

Grant agreement ID: 823712

Status

Ongoing project

  • Start date

    1 October 2019

  • End date

    30 September 2023

Funded under:

H2020-EU.1.4.1.3.

  • Overall budget:

    € 8 345 472,50

  • EU contribution

    € 7 992 822,50

Coordinated by:

UNIVERSITY COLLEGE LONDON

United Kingdom

Objective

CompBioMed2 is a proposal for the second phase of the Computational Biomedicine Centre of Excellence (CoE), CompBioMed, an outward facing CoE comprising members from academia, industry and the healthcare sector. CompBioMed has established itself as a hub for practitioners in the field, successfully nucleating a substantial body of research, education, training, innovation and outreach within the nascent field of Computational Biomedicine. Computational Biomedicine is an emergent technology that will enable clinicians to develop and refine personalised medicine strategies ahead of their clinical delivery to the patient. Medical regulatory authorities are currently embracing the prospect of using in silico methods in the area of clinical trials and we intend to be in the vanguard of this activity, laying the groundwork for the application of HPC-based Computational Biomedicine approaches to a greater number of therapeutic areas. The HPC requirements of our users are as diverse as the communities we represent. We support both monolithic codes, potentially scaling to the exascale, and complex workflows requiring support for advanced execution patterns. Understanding the complex outputs of such simulations requires both rigorous uncertainty quantification and the embrace of the convergence of HPC and high performance data analytics (HPDA). CompBioMed2 seeks to combine these approaches with the large, heterogeneous datasets from medical records and from the experimental laboratory to underpin clinical decision support systems. CompBioMed2 will continue to support, nurture and grow our community of practitioners, delivering incubator activities to prepare our most mature applications for wider usage, providing avenues that will sustain CompBioMed2 well-beyond the proposed funding period.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

UNIVERSITY COLLEGE LONDON

Address

Gower Street
Wc1e 6bt London

United Kingdom

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 1 730 971,25

Participants (15)

UNIVERSITEIT VAN AMSTERDAM

Netherlands

EU Contribution

€ 573 125

THE UNIVERSITY OF EDINBURGH

United Kingdom

EU Contribution

€ 420 646,25

BARCELONA SUPERCOMPUTING CENTER - CENTRO NACIONAL DE SUPERCOMPUTACION

Spain

EU Contribution

€ 624 353,75

SURFSARA BV

Netherlands

EU Contribution

€ 514 510

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

United Kingdom

EU Contribution

€ 769 107,50

UNIVERSITE DE GENEVE

Switzerland

EU Contribution

€ 397 000

THE UNIVERSITY OF SHEFFIELD

United Kingdom

EU Contribution

€ 362 912,50

CBK SCI CON LIMITED

United Kingdom

EU Contribution

€ 763 125

UNIVERSIDAD POMPEU FABRA

Spain

EU Contribution

€ 357 000

BAYERISCHE AKADEMIE DER WISSENSCHAFTEN

Germany

EU Contribution

€ 455 000

ACELLERA LABS SL

Spain

EU Contribution

€ 178 125

EVOTEC (UK) LIMITED

United Kingdom

EU Contribution

€ 133 875

BULL SAS

France

EU Contribution

€ 163 900

JANSSEN PHARMACEUTICA NV

Belgium

EU Contribution

€ 169 000

ALMA MATER STUDIORUM - UNIVERSITA DI BOLOGNA

Italy

EU Contribution

€ 380 171,25

Project information

Grant agreement ID: 823712

Status

Ongoing project

  • Start date

    1 October 2019

  • End date

    30 September 2023

Funded under:

H2020-EU.1.4.1.3.

  • Overall budget:

    € 8 345 472,50

  • EU contribution

    € 7 992 822,50

Coordinated by:

UNIVERSITY COLLEGE LONDON

United Kingdom